Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Dr. Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Professor First Hospital of Jilin University China

Professor Jiancheng Xu (MD, PhD) is a distinguished clinical microbiologist with over 20 years of experience in laboratory medicine. He currently serves as Professor, Doctoral Supervisor, and Deputy Director of the Department of Laboratory Medicine at the First Hospital of Jilin University, China. A joint-training PhD scholar from the University of Louisville, USA, he has made significant contributions to microbiology, diabetic complications, and laboratory diagnostics. He is also a reviewer for several international journals and an influential figure in multiple national medical associations. Outside the lab, he enjoys running and badminton. πŸƒβ€β™‚οΈπŸΈ

Profile

Orcid

πŸŽ“ Education

Professor Xu’s academic path reflects a commitment to excellence. He earned his MD from Norman Bethune University of Medical Sciences (1995–2000), followed by an MS in Laboratory Medicine and a PhD in Internal Medicine from Jilin University (2002–2010). He undertook a joint PhD program at the University of Louisville (2008–2009), enhancing his global research exposure. He further completed a postdoctoral fellowship in Laboratory Medicine at China Medical University (2012–2016), solidifying his scientific and clinical foundation. πŸŽ“πŸ§ͺ

πŸ’Ό Professional Experience

Professor Xu has advanced steadily through academic and clinical ranks. Beginning as a Research Assistant (2000–2006), he became an Attending Physician (2006–2010), Associate Professor (2010–2014), and finally Professor in 2014 at the First Hospital of Jilin University. He currently serves as the Deputy Director of the Department of Laboratory Medicine, mentoring numerous doctoral candidates and leading transformative research. πŸ§‘β€πŸ«πŸ₯

πŸ”¬ Research Interests

Professor Xu’s research spans across vital domains:

  1. 🧠 Mechanism of Diabetic Complications

  2. 🦠 Bacterial Resistance Mechanisms and Surveillance

  3. πŸ“Š Establishment of Reference Intervals for Clinical Tests

  4. πŸ€– Disease Prediction Modeling with Machine Learning

  5. 🧬 Trace Element Metabolism in Diabetic Models

His work integrates clinical insights with computational analytics to develop predictive tools and diagnostic advancements in laboratory medicine.

πŸ† Awards & Honors

Professor Xu’s outstanding contributions have earned him numerous accolades and appointments:

  • πŸ… Chairman, Society of Laboratory Medicine, Jilin Medical Security Association

  • πŸ… Vice Chairman, Youth Committee, Chinese Society of Laboratory Medicine

  • πŸ… Vice Chairman, Youth Committee, Jilin Medical Association

  • πŸ… Member, Standing Committees across multiple national and provincial laboratory medicine societies

  • πŸ“š Editorial Board Member, Chinese Journal of Laboratory Medicine

  • πŸ§ͺ Reviewer for Biological Trace Element Research, OMICS, and others

He has successfully led over 33 funded research projects, totaling Β₯7.04 million RMB.

πŸ“š Publications Top Notes: 

Professor Xu has authored over 125 peer-reviewed articles, with an H-index of 16 and over 1269 citations. His top publications as a corresponding author include:

🧬 A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings
Virologica Sinica, 2020 – Cited by 39 articles

🧫 The Function of T Follicular Helper Cells in the Autoimmune Liver Diseases
Journal of Immunology Research, 2020 – Cited by 27 articles

πŸ§ͺ Negative Results in Nucleic Acid Test of COVID-19 Patients: Assessment from Clinical Laboratories
Annals of Palliative Medicine, 2020 – Cited by 18 articles

βš–οΈ Age- and Sex-Specific Pediatric Reference Intervals of Serum Electrolytes
American Journal of Clinical Pathology, 2020 – Cited by 21 articles

🧫 Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2
Health Security, 2020 – Cited by 14 articles

❀️ Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in COVID-19
BioMed Research International, 2020 – Cited by 33 articles

Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation